Injectable formulations often encounter challenges such as sensitivity to oxidation, chemical and physical instability, susceptibility to microbial contamination, and more. LDS technology addresses these challenges by encapsulating active pharmaceutical ingredients (APIs) within its innovative nano-domains, providing key advantages: (1) thermodynamic stability; (2)r Injection pain upon injection; (3) improved API solubility; (4) decreased microbial contamination; (5) sterilization by filtration (eliminating the need for thermal heating, protecting heat-sensitive APIs); (6) enhanced bioavailability; and more

These benefits position LDS technology as a robust, efficient, and reliable solution for parenteral drug delivery systems.